Low density lipoprotein (LDL) modified by incubation with phospholipase C (PLC-LDL) aggregates in solution and is rapidly taken up and degraded by human and mouse macrophages, producing foam cells in vitro. Human, mouse, and rabbit macrophages degraded ISI-labeled PLC-LDL (1'I-PLC-LDL) more rapidly than native 'SI-labeled LDL (12'I-LDL), while nonphagocytic cells such as human fibroblasts and bovine aortic endothelial cells degraded 12'I-PLC-LDL more slowly than 12'I-LDL. This suggested the mechanism for internalization of PLC-LDL was phagocytosis. When examined by electron microscopy, mouse peritoneal macrophages appeared to be phagocytosing PLC-LDL. The uptake and degradation of 'uI-PLC-LDL by human macrophages was inhibited >80% by the monoclonal antibody C7 (IgG2b) produced by hybridoma C7, which blocks the ligand binding domain of the LDL receptor. Similarly, methylation of 125I-LDL ('25I-MeLDL) prior to treatment with phospholipase C decreased its subsequent uptake and degradation by human macrophages by >90%. The uptake and degradation of phospholipase C-modified 125I-MeLDL by macrophages could be restored by incubation of the methylated lipoprotein with apoprotein E, a ligand recognized by the LDL receptor. These results indicate that macrophages internalize PLC-LDL by LDL receptor-dependent phagocytosis.
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The morphological hallmark of the early cellular lesion of atherosclerosis is the presence of lipid-laden foam cells, predominantly derived from macrophages (1) . The mechanisms that lead to accumulation of cholesterol by these cells remain unknown. The major pathway for delivery of exogenous cholesterol to most cells is uptake of low density lipoprotein (LDL) (2) . Because LDL receptor activity is tightly coupled to the level of cellular cholesterol, it is likely that a pathway separate from LDL receptor-mediated endocytosis is responsible for the pathological accumulation of cholesterol.
Macrophages are also able to ingest particulate material such as senescent cells and microorganisms by phagocytosis (3) . Phagocytosis requires initial binding to specific receptors on the cell surface. After binding, the plasma membrane of the macrophage surrounds the particle by the interaction of ligands distributed circumferentially around the particle with receptors on the surface of the cell (4) .
The receptor-mediated endocytosis of lipoproteins has been widely studied as a potential mechanism for foam-cell formation (2, 5) . In contrast, the possibility that phagocytosis might mediate the unregulated accumulation of cholesterol by macrophages has received little attention. When LDL is modified by treatment with phospholipase C (PLC-LDL), =70% of the phospholipid of LDL (25-35 g ) by the method of Edelson and Cohn (8) . After one wash in Dulbecco's modified Eagle's medium, the cells were plated at 1 x 106 cells per 16-mm well in the same medium supplemented with 20% (vol/vol) fetal calf serum and 100 units of penicillin and 100 ,g of streptomycin per ml. After a 2-hr incubation, nonadherent cells were removed from the human and mouse macrophages by three washes with serum-free medium. The mouse cells were used for experiments 24 hr after plating, while human cells were incubated for 7-14 days prior to use. Rabbit alveolar macrophages were obtained by pulmonary lavage with phosphate-buffered saline (9) and then were plated and cultured as described for mouse macrophages.
Other cells. Human skin fibroblasts were obtained by punch biopsy from the anterior thighs of healthy volunteers and cultured as described (10) . Human arterial smooth muscle cells were isolated from medial explants of aorta by the method of Ross (11) and cultured in Dulbecco's modified Eagle's medium (6) . Bovine aortic endothelial cells, cultured as described (12) Proc. Natl. Acad. Sci. USA 86 (1989) mM; phenylmethylsulfonyl fluoride, 1 gM) by discontinuous density gradient ultracentrifugation by the method of Chung et al. (14) as described (6) . LDL was iodinated by using Na125I (15) Phospholipid hydrolysis. The extent of phospholipid hydrolysis of PLC-LDL was estimated by measuring the appearance of aqueous phosphorous colorimetrically after digestion of the released phosphate polar head group with alkaline phosphatase (20 (21) with bovine serum albumin as the standard. The total cholesterol, cholesteryl ester, triglyceride, and phospholipid of PLC-LDL and LDL were measured enzymatically (22) . For transmission electron microscopy, mouse peritoneal macrophages were fixed in situ with 3% (wt/vol) glutaraldehyde, stained with 1% osmium tetroxide, poststained with uranyl acetate and lead citrate, and examined with a JEOL 100B electron microscope. Nondenaturing gradient gel electrophoresis was carried out as described (23) .
All results are means of duplicate determinations unless otherwise stated. RESULTS When LDL was incubated with increasing concentrations of phospholipase C, the light scattering ofthe solution increased dramatically, measured as the increase in optical density at 450 nm (Fig. 1) . The change in turbidity of the PLC-LDL solution and extent of phospholipid hydrolysis were related in a linear manner (Fig. 1 Inset). Little additional change in turbidity or phospholipid hydrolysis was observed at concentrations of phospholipase C > 1 unit/ml. The On agarose gel electrophoresis, PLC-LDL migrated slightly more rapidly than did LDL, indicating that no major changes had occurred in the charge-to-mass ratio of the modified lipoprotein. In contrast to oxidized LDL (6), the apo B100 of PLC-LDL remained intact on sodium dodecyl sulfate/polyacrylamide gel electrophoresis. PLC-LDL also showed no evidence of lipid peroxidation as assayed by the appearance of material reactive with thiobarbituric acid.
Human monocyte-derived macrophages incubated with 1251-labeled PLC-LDL (125I-PLC-LDL) internalized and degraded the lipoprotein at up to 40 times the rate of '25I-LDL as assessed by the appearance of acid-soluble 125I radioactivity in the medium (Fig. 2A) . Similar findings were obtained by using the stimulation of incorporation of [14C]oleic acid into cholesteryl ester as an index of cholesterol delivery to the macrophages (Fig. 2B ). At lipoprotein concentrations > 100 ,g/ml, 125I-PLC-LDL was degraded more rapidly than 125I-labeled acetylated LDL (125I-AcLDL) by human macrophages ( Fig. 2A) . The uptake and degradation of 125I1 PLC-LDL was nonsaturable at concentrations of lipoprotein up to 1000 ,ug/ml (data not shown). The nonsaturable uptake of 1251-PLC-LDL is consistent with a mechanism of internalization by macrophages that is not limited by receptor number. Alternatively, the molar concentration of PLC-LDL might be much lower than the protein concentration would suggest. 1251-LDL incubated with heat-inactivated phospholipase C (1 min at 100°C) did not aggregate in solution, and uptake by human macrophages was unchanged relative to native I251-LDL.
By light microscopy, mouse peritoneal macrophages incubated with 500 ,ug of PLC-LDL per ml for 12 hr contained many cytoplasmic inclusion bodies (data not shown) resembling the foam cells of atherosclerotic lesions (24 To investigate potential mechanisms responsible for internalization of PLC-LDL, we tested the ability of a variety of cell types to take up and degrade 1251-PLC-LDL. Mouse peritoneal macrophages, human monocyte-derived macrophages, and rabbit alveolar macrophages degraded 6-13 times more 1251-PLC-LDL than native 125I-LDL during a 5-hr incubation with 100 ,g of radiolabeled lipoprotein per ml (Table 1) . Under identical conditions, human skin fibroblasts, human arterial smooth muscle cells, and bovine aortic endothelial cells degraded little 125I-PLC-LDL relative to 5I-LDL (Table 1) . Similar results were obtained by using the incorporation of [14C]oleate into [14C]cholesteryl ester as an index for delivery of lipoprotein cholesterol to the cells (data not shown). Thus, only macrophages internalized and degraded 125I-PLC-LDL more rapidly than 1"I-LDL, consistent with phagocytosis as a potential mechanism for the uptake of PLC-LDL by cells. When conditioned medium from human macrophages incubated with PLC-LDL was subsequently incubated with 125I-PLC-LDL in the absence of cells, no 125I-labeled degradation products appeared in the medium. These results indicate that proteases released by the macrophages were not responsible for the increased rate of degradation of 125I-PLC-LDL.
When mouse peritoneal macrophages incubated with 500 ,ug of PLC-LDL per ml were examined by transmission electron microscopy, particulate material resembling aggre- The uptake and degradation of 125I-lipoprotein (100 jug/ml) were determined after a 5-hr incubation as described in Fig. 2A . Values are the means ± SD of triplicate determinations.
gated lipoprotein was observed outside the cells (Fig. 3A) . No such material was observed when cells were incubated with the same concentration of either LDL or AcLDL ( Fig. 3B and C). This particulate material was probably PLC-LDL. In many electron micrographs of mouse macrophages incubated with PLC-LDL, pseudopodia extending from the cell surface surrounded the aggregated material, and similar material was present in cytoplasmic vacuoles (Fig. 3A) . Pseudopodia surrounding aggregated material were not observed in mouse macrophages incubated with LDL or AcLDL. Numerous vacuoles containing multivesicular bodies and non-membrane-bound electron-dense cytoplasmic inclusions appeared in the cells after 6-12 hr of incubation with PLC-LDL (Fig.  3A) . These vacuoles and cytoplasmic inclusions are probably derived from digested PLC-LDL and resemble those found in foam cells of the atherosclerotic lesion (24, 25) . Mouse macrophages incubated with AcLDL contained smaller numbers of similar-appearing vacuoles and cytoplasmic inclusions (Fig. 3C) , while macrophages incubated with LDL lacked vacuoles or inclusions (Fig. 3B) . Phagocytosis requires initial binding of particulate material to a cell-surface receptor, followed by internalization (3) . Macrophages possess at least two receptors able to interact with lipoproteins, the LDL receptor and the scavenger receptor (5). Human and rabbit macrophages degraded 1251-PLC-LDL more rapidly than 125I-AcLDL, while mouse macrophages degraded 125I-PLC-LDL less rapidly than 125I[ AcLDL (Table 1) . Bovine aortic endothelial cells, which degraded little 125I-PLC-LDL, rapidly took up and degraded 125I-AcLDL. The ability to dissociate the rates of degradation of 125I-PLC-LDL and 125I-AcLDL by these cell types suggests that the scavenger receptor is unlikely to be involved in the uptake of PLC-LDL.
The C7 hybridoma-produced IgG2b-type monoclonal antibody blocks binding of LDL to its receptor, inhibiting the uptake and degradation of LDL by cells (26) . In the presence of the C7 monoclonal antibody, the degradation of both 125I-LDL and 125I-PLC-LDL by human macrophages was inhibited by >80% (Table 2) . Under identical conditions, the degradation of 125I-AcLDL was inhibited 14% by C7 monoclonal antibody. Similar results were obtained using the incorporation of [14C]oleate into cholesteryl ester as an index for delivery of lipoprotein cholesterol to the cells (data not shown). An irrelevant IgG monoclonal antibody OKM1, which recognizes a component of the cell-surface complex mediating neutrophil and monocyte adhesion (27) , had little effect on the rates of degradation of either 125I-LDL or 125I-PLC-LDL by human macrophages (Table 2) . Thus, it is likely that 125I-PLC-LDL was interacting with the cell surface of human macrophages via the LDL receptor.
Cell Biology: Suits et al. When the lysine residues of apolipoprotein B100 of LDL are reductively methylated, recognition of the lipoprotein by the LDL receptor on fibroblasts is lost (19) . Similarly, "MI-Iabeled methylated LDL (125I-MeLDL) was taken up and degraded at only 26% of the rate of 125I-LDL by human macrophages (Table 2) . When '"'I-MeLDL was treated with phospholipase C under standard conditions, it was taken up and degraded at only 9%o of the rate of 125I-PLC-LDL (Table   2 ). MeLDL and native LDL incubated with phospholipase C aggregated to about the same extent, measured as the change in optical density at 450 nm (0.870 and 0.960, respectively). This suggests that the loss of macrophage degradation of phospholipase C-modified 125I-MeLDL could not be attrib- The uptake and degradation of 1251-lipoprotein (10 ,ug/ml) by human macrophages were determined after a 5-hr incubation as described in Fig. 2A (28, 29) . When 125I-MeLDL was preincubated with apolipoprotein E, the degradation of the methylated lipoprotein by human macrophages was increased 3-fold (Table 2) . Similarly, the uptake and degradation of phospholipase C-treated 125I-MeLDL was increased 7-fold by prior incubation with apolipoprotein E ( (30) . Macrophages then internalize the PLC-LDL by phagocytosis. Phagocytosis probably occurs by a zipper-like mechanism (3, 4) , with progressive apposition of the surface membrane around the lipoprotein aggregates by the interaction of apolipoprotein B100 with the LDL receptor.
The results reported here suggest that any mechanism that induces aggregation of LDL might promote phagocytosis of the lipoprotein by a receptor-dependent process. LDL incubated with mast cell granules (31) or insoluble proteoglycan-LDL complexes (32-34) could be taken up by this mechanism. Recently, extracellular forms of phospholipases have been reported (35) , suggesting that the mechanism of aggregation that we have described might occur in vivo. An alternate possibility is that a source of cholesterol, such as senescent cells or secreted platelet products (36) (37) (38) , that has acquired an exchangeable ligand recognized by the LDL receptor (such as apolipoprotein E) could be phagocytosed by macrophages in the arterial wall. Alternatively, phagocytosis of aggregated LDL might activate monocytes, enhancing their migration into the arterial wall or altering their secretory function (39) .
Nonphagocytic cells that possess LDL receptors failed to degrade PLC-LDL at a significant rate. This suggests that particles above a certain size may not be able to undergo LDL receptor-mediated endocytosis. Macrophages, using cellular mechanisms developed specifically for ingesting particulate material, overcome this size limitation. These cells ingest massive quantities of cholesterol by LDL receptordependent phagocytosis of PLC-LDL, rapidly producing foam cells in vitro.
